Contact:
Scott Stoogenke
VP, Marketing
Informed Medical Communications
379 Thornall Street
Edison, NJ 08837 732-205-8394; scott.stoogenke@informedmedical.com
Informed Medical Communications adopts newly enhanced Compliance Policy
Edison, NJ – June 23, 2008 Informed Medical Communications (IMC), a leading provider
of peer-to-peer medical forums for the bio-pharmaceutical industry, today announced
adoption of an enhanced compliance policy and the appointment of Dr. Jaime Nguyen
as Medical Director/ Compliance Officer (CO). The policy specifically outlines the
role of the CO as well as methods for handling written policies/procedures, training/education,
internal monitoring/auditing, reporting/lines of communication, and prompt response
and corrective action for violations and detected problems. “The changes reflect
IMC’s commitment to compliance with the laws, regulations, and guidelines that govern
pharmaceutical promotional and marketing activities,” said Steve Budd, CEO of IMC
“Our ongoing investment in this critical competency will enable us to partner more
closely with our clients to ensure that the medical communications programs we execute
on their behalf meet the highest standards for promotional compliance.”
Dr. Nguyen was appointed to this position following two years of distinguished service
as a moderator on numerous IMC programs. Nguyen holds an MD from MSIH and Columbia
University Medical Center, an MPH from the University of Pittsburgh, and an MS in
Medicinal Chemistry and Pharmacology from the University of Toledo. Additionally,
Nguyen is a certified Pharmaceutical, Biotech and Medical Device Compliance Officer.
Prior to joining IMC in 2006, Nguyen had over 10 years of experience in the areas
of pharmacology and drug design, medicine and public health, and healthcare analysis.
She also held numerous international clinical leadership roles across multiple therapeutic
areas and served on two federal advisory committees while working for the Department
of Health and Human Services.
“In the current highly regulated environment, and consistent with our ongoing focus
on mitigating risk for our clients, a comprehensive Compliance Policy and dedicated
CO are essential,” noted Kathleen Bresette, President of The Peer Group (an IMC
company). “We are delighted to have someone with Jaime’s qualifications and enthusiasm
supporting IMC and our clients in this capacity.” IMC’s Compliance Policy may be
found on the IMC website.
About Informed Medical Communications
Informed Medical Communications, headquartered in Edison, NJ, is an interactive
medical marketing group of companies providing services to the biopharmaceutical
industry. The companies include
The Peer Group and RxDialogue, industry innovators
and leaders in conducting general and specialty peer-to-peer medical programs, respectively.
Additionally, IMC’s major businesses are enhanced by MRxHealth,
the market research and consulting infrastructure that supports IMC’s ongoing development
and effectiveness of non-traditional marketing programs for biopharmaceutical clients,
and Leading Through Dialogue, a communications training service
for elite skill development in three areas: (1) leadership, (2) sales, and (3) training/facilitation.
The IMC network of companies delivers integrated marketing programs for pharmaceutical
marketers, with the goal of improving the dialogue among healthcare practitioners
in understanding health conditions and their medical options. IMC's management team
has extensive experience in healthcare marketing, technology, pharmaceutical client
services and program delivery. IMC is a private-equity backed, privately held company.
